Amer Zeidan/LinkedIn
Sep 6, 2026, 10:51
Amer Zeidan: Looking Ahead to ESH MDS 2026 in Ireland
Amer Zeidan, Chief of Division of Hematologic Malignancies at Yale Comprehensive Cancer Center, Professor of Medicine, Medical Oncology and Hematology at Yale University, shared a post on LinkedIn:
“Looking forward to this excellent meeting on MDS by the European School of Haematology ESH MDS 2026 in Ireland and hope to meet many of you there…”
Stay updated with Hemostasis Today.
-
Sep 6, 2026, 12:27Alan Nurden: Inherited GPIV (CD36) Deficiency Linked to Bleeding for the First Time
-
Sep 6, 2026, 12:19Zaid Siddiqui: Hemophilia From a Broader Perspective
-
Sep 6, 2026, 12:13Claire Harrison: MPN Does Not Define Your Dreams
-
Sep 6, 2026, 12:12Ilenia Calcaterra: Beyond Bleeding Control Emicizumab and the Evolution of Joint Health in Hemophilia A
-
Sep 6, 2026, 12:11Agisilaos Zerdelis: My CRTH Journey From Trial Idea to Clinical Research
-
Sep 6, 2026, 12:06Jan Geissler: Shaping the Future of Hematology Research at EHA CRTH
-
Sep 6, 2026, 11:58Reem Alrabeh: An Honorable Meeting with a Leader in Hematopathology
-
Sep 6, 2026, 10:52Panagiotis Christoforou: Six Years of Service, Growth and Global Connection with WFH
-
Sep 6, 2026, 10:50David Smadja: Unveiling the Endothelium’s Role in Thrombosis at ISTH 2026